GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Scopus Biopharma SCPS · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Scopus Biopharma — daily SCPS Delayed
Market value
$16,832
Last close × shares
Volume
2.4k
Shares, 9 Nov 2026

About Scopus Biopharma

Its shares trade under the ticker SCPS. It has been listed since 16 December 2020.

Scopus Biopharma, Inc. is a biopharmaceutical company, which engages in the development of therapeutics targeting diseases with unmet medical needs. The company is headquartered in New York City, New York. The company went IPO on 2020-12-16. The firm is focused on the development of its immuno-oncology programs. The Company’s Duet Platform relies on an immuno-oncology with a suite of bifunctional oligonucleotides that activate antigen-presenting cells (APCs) within the tumor microenvironment, while alleviating tumor immunosuppression to jump-start T cell-mediated immune responses. The Duet Platform is comprised of three bifunctional oligonucleotides that consists of a toll-like receptor 9 (TLR9) agonist linked with a signal transducer and activator of transcription 3 (STAT3) inhibitor, which include CpG-STAT3siRNA (DUET-01), CpG-STAT3ASO (DUET-02) and CpG-STAT3decoy (DUET-03). The firm is developing DUET-01 for the treatment of relapsed or refractory B-cell non-Hodgkin lymphoma. DUET-02 is being developed for systemic delivery for treatment of solid tumors such as prostate or kidney cancers.

Figures and description from our data supplier, not checked against the company's own report.

More about Scopus Biopharma →

Latest on Scopus Biopharma

Our reporting

We have not reported on Scopus Biopharma yet.

Next results

2 Dec 2026

Due on 2 Dec 2026. Analysts expect earnings of -0.22 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Scopus Biopharma's ticker?

Scopus Biopharma trades as SCPS on its US listing, under ISIN US8091711015.

What was Scopus Biopharma's last closing price?

0.00 on 9 Nov 2026. The figure is in USD and is never converted.

When does Scopus Biopharma next report results?

Results are expected on 2 Dec 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.